SANOFI
Sanofi India Limited (SANOFI) Stock Analysis
Sanofi India Limited is the Indian subsidiary of global healthcare company Sanofi, marketing pharmaceuticals and vaccines. It sells prescription medicines in diabetes, cardiology, and specialty therapies through medical representatives and hospitals. The company benefits from global R&D pipelines adapted for India. It is listed on Indian stock exchanges.
Healthcare › Drug Manufacturers - General
₹2,942.10
-0.11% 1W | -36.80% 52W
Market Cap
6.8k CR
P/E Ratio
20.9
52W High
₹4898
52W Low
₹2907.4
Div. Yield
4.16%
Beta
0.2
50 DMA
₹3131
200 DMA
₹3437.1
Profit Margin
17.9%
Inst. Own.
22.9%
⚡ APPROACHING SUPPORT
⚡ APPROACHING SUPPORT
Fundamentals
Profit & Loss
| Metric | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|---|---|
| Sales | 515 | 491 | 469 | 511 | 464 | 524 | 515 |
| Expenses | 393 | 377 | 370 | 374 | 348 | 404 | 397 |
| Operating Profit | 122 | 114 | 100 | 137 | 116 | 120 | 118 |
| OPM % | 24% | 23% | 21% | 27% | 25% | 23% | 23% |
| Other Income | 57 | 82 | 77 | 41 | 21 | 2 | 14 |
| Interest | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 9 | 9 | 9 | 9 | 9 | 9 | 10 |
| Profit before tax | 169 | 186 | 167 | 169 | 127 | 113 | 122 |
| Tax % | 27% | 18% | 18% | 19% | 19% | 27% | 25% |
| Net Profit | 123 | 152 | 138 | 137 | 103 | 82 | 91 |
| EPS in Rs | 53.43 | 66.04 | 59.87 | 59.39 | 44.87 | 35.74 | 39.70 |
| Metric | Dec 2023 | Dec 2024 |
|---|---|---|
| Sales | 1,996 | 2,013 |
| Expenses | 1,508 | 1,522 |
| Operating Profit | 488 | 491 |
| OPM % | 24% | 24% |
| Other Income | 317 | 78 |
| Interest | 2 | 2 |
| Depreciation | 36 | 37 |
| Profit before tax | 767 | 531 |
| Tax % | 21% | 22% |
| Net Profit | 603 | 413 |
| EPS in Rs | 262.13 | 179.70 |
| Dividend Payout % | 64% | 65% |
Shareholding Pattern
Promoters60.40%
FIIs5.61%
DIIs23.06%
Public10.94%
Promoters60.40%
FIIs5.57%
DIIs22.28%
Public11.75%
Promoters60.40%
FIIs5.55%
DIIs21.30%
Public12.75%
Promoters60.40%
FIIs5.65%
DIIs21.12%
Public12.84%
Promoters60.40%
FIIs5.69%
DIIs19.87%
Public14.05%
Promoters60.40%
FIIs6.71%
DIIs19.46%
Public13.43%
Promoters60.40%
FIIs6.11%
DIIs22.88%
Public10.61%
Promoters60.40%
FIIs5.58%
DIIs23.02%
Public11.01%
Promoters60.40%
FIIs5.65%
DIIs21.12%
Public12.84%
Promoters60.40%
FIIs5.69%
DIIs19.87%
Public14.05%
SANOFI
Holdings Analysis
Key strengths & risk signals
57
Overall
56
Fundamental
58
Technical
Risks (4)
Cannot calculate PEG - insufficient growth data.
POOR YEAR! Stock declined 36.8% in the last year.
WEAK POSITION! Current price (2942.1) is below both moving averages.
WEAK! Trading at 1.7% of 52W range - near yearly lows.
Strengths (4)
VERY GOOD DIVIDEND! 4.16% yield - strong income generator.
BULLISH SENTIMENT! In last 30 days: 9 up days, 21 down days. Avg volume on up days: 24,841 vs down days: 12,499. Ratio: 1.99x
LOW VOLATILITY! Beta of 0.20 - stable stock, less market risk.
APPROACHING OVERSOLD! RSI at 33.0 - watch for reversal.
Fundamental & Technical Analysis
57Overall
56Fundamental
58Technical
Fundamental Breakdown
Growth Quality
4/30
Revenue CAGR: -12.6% (DECLINING, 2/15). Profit CAGR: -19.3% (DECLINING, 2/15).
Profit Margin
6/10
GOOD EFFICIENCY! 17.9% profit margin - above average profitability.
PEG Valuation
1/10
Cannot calculate PEG - insufficient growth data.
Dividend Yield
9/10
VERY GOOD DIVIDEND! 4.16% yield - strong income generator.
Debt to Equity
10/10
VERY LOW DEBT! D/E of 0.00 - excellent financial health.
Public Holding
20/20
VERY LESS PUBLIC HOLDING! 13.22% public ownership - strong promoter/institutional control.
Stability Index
6/10
MODERATE STABILITY! 2 revenue dips in history. Acceptable but monitor closely.
Technical Breakdown
Moving Averages
5/10
BEARISH TREND! 50-day average (3131.0) is below 200-day average (3437.1) - negative signal.
Price Position
2/10
WEAK POSITION! Current price (2942.1) is below both moving averages.
Trend Pattern
10/20
TESTING SUPPORT! Stock is at key support level.
52W Performance
0/10
POOR YEAR! Stock declined 36.8% in the last year.
Volume Sentiment
30/30
BULLISH SENTIMENT! In last 30 days: 9 up days, 21 down days. Avg volume on up days: 24,841 vs down days: 12,499. Ratio: 1.99x
RSI
4/5
APPROACHING OVERSOLD! RSI at 33.0 - watch for reversal.
52W Range
1/5
WEAK! Trading at 1.7% of 52W range - near yearly lows.
Momentum
1/5
NEGATIVE MOMENTUM! Price declined across timeframes - down 0.1% (1 week), 5.4% (1 month), 13.8% (3 months).
Beta
5/5
LOW VOLATILITY! Beta of 0.20 - stable stock, less market risk.
SANOFI
Concall / Investor Presentation
Earnings call transcripts & AI summaries
| Quarter | Concall | Summary |
|---|---|---|
| Q1FY272026-08-10 | Concall PDF | |
| Q3FY262026-03-05 | Concall PDF | |
| Q2FY262025-11-04 | Concall PDF |
Peer Comparison
Healthcare · Drug Manufacturers - General · 8 stocks
| Stock | Price | P/E | Profit Margin | Revenue CAGR 5Y | Profit CAGR 5Y | 52W Change | Stock Strength | Trendline | YoY Profit | QoQ Profit | YoY Revenue | QoQ Revenue |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SANOFI | ₹2,942.10 | 20.9 | 17.9% | -12.6% | -19.3% | -36.8% | 57 | APPROACHING SUPPORT | +20.1% | -18.6% | +7.7% | -7.3% |
| SENORES | ₹1,318.40 | 46.4 | 18.7% | 159.1% | 139.2% | +79.3% | 77 | APPROACHING RESISTANCE | +55.8% | -2.8% | +35.9% | +2.9% |
| SANOFICONR | ₹3,548.70 | 30.7 | 28.0% | 27.0% | 20.7% | -22.8% | 69 | BREAKDOWN | +13.3% | +1.5% | +6.7% | +2.8% |
| MARKSANS | ₹311.00 | 27.3 | 16.3% | 16.7% | 16.2% | +73.9% | 70 | BREAKDOWN | +169.6% | +6.1% | +35.6% | -1.8% |
| PFIZER | ₹3,814.00 | 23.7 | 28.6% | 1.3% | 5.0% | -28.4% | 51 | BREAKOUT | +6.6% | +2.4% | +8.3% | +3.8% |
| SMSPHARMA | ₹450.50 | 40.1 | 11.4% | 19.3% | – | +44.6% | 74 | BREAKDOWN | +2.0% | -36.1% | +5.6% | -13.0% |
| SAIPARENT | ₹487.30 | 168 | 3.9% | 126.1% | 111.8% | +19.3% | 67 | APPROACHING RESISTANCE | +464.3% | -1,416.7% | +435.0% | -33.6% |
| NGLFINE | ₹2,784.60 | 30.1 | 10.7% | 21.8% | 32.9% | +89.0% | 79 | APPROACHING SUPPORT | +100.0% | +36.3% | +33.6% | -6.7% |
Data from TradeAlone · Updated daily
